2 terminated. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Terminated 2 |
Follow Skin Abnormalities: new trials by email Literature Review of Skin Abnormalities trials Research Report on Skin Abnormalities
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Effects of HP828-101 for Moisture Associated Skin Damage HP828-101 - Skin Abnormalities | Early Phase 1 | Terminated | Healthpoint | 7 | 2010-04-01 | 2013-12-06 |
| Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB) Palifermin, Fludarabine, Busulfan - Epidermolysis Bullosa | Early Phase 1 | Terminated | Columbia University | 3 | 2009-08-20 | 2021-08-17 |
Epidermolysis Bullosa (1) · Epidermolysis Bullosa Dystrophica (1)
Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Collagen Diseases (1) · Connective Tissue Diseases (1) · Genetic Diseases, Inborn (1) · Skin Diseases, Genetic (1) · Skin Diseases, Vesiculobullous (1)
Alemtuzumab (1) · Busulfan (1) · Fibroblast Growth Factor 7 (1) · Lorazepam (1) · Tacrolimus (1) · fludarabine (1) · fludarabine phosphate (1)
Columbia University (1) · Healthpoint (1)
United States (2)
Angela Christiano, PhD (1) · Herbert B Slade, MD (1) · Neeta Nayak, MD (1)